Martin F Fromm

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 34

Top Venues

Clinical pharmacology and therapeutics

Journal of clinical medicine

Pharmaceutics

Cancers

Friedrich-Alexander-Universität Erlangen-Nürnberg

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Friedrich-Alexander-Universität Erlangen-Nürnberg May 01 2004

Germany

Director and Chair :: Inst. of Exp. and Clin. Pharmacology and Toxicology; Clin. Pharmac. and Clin. Tox.

Publications

Lisa Cuba, Pauline Dürr, Frank Dörje, Martin F Fromm, Katja Schlichtig
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy. Clinical pharmacology and therapeutics 116 (1) (2024)
Daniela B Surrer, Sarah Schüsser, Martin F Fromm, Martin F Fromm, Arne Gessner
Transport of aromatic amino acids l-tryptophan, l-tyrosine, and l-phenylalanine by the organic anion transporting polypeptide (OATP) 3A1. The FEBS journal (2024)
Lisa Cuba, Pauline Dürr, Katja Gessner, Babette Häcker, Rainer Fietkau, Jürgen Siebler, Marianne Pavel, Markus F Neurath, Carola Berking, Bernd Wullich, Valeska Brückl, Matthias W Beckmann, Martin F Fromm, Frank Dörje
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. JCO oncology practice (2024)
Arne Gessner, Martin F Fromm, Pia Wenisch, Markus R Heinrich, Peter Stopfer, Martin F Fromm, Fabian Müller
New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans. Clinical pharmacology and therapeutics (2024)
Michael I Sponfeldner, Wahram Andrikyan, Renke Maas, Martin F Fromm
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC. Clinical pharmacology and therapeutics (2024)
Lisa Cuba, Pauline Dürr, Frank Dörje, Martin F Fromm, Katja Schlichtig
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy. Clinical pharmacology and therapeutics (2024)
Lisa Cuba, Pauline Dürr, Katja Gessner, Babette Häcker, Rainer Fietkau, Jürgen Siebler, Marianne Pavel, Markus F Neurath, Carola Berking, Bernd Wullich, Valeska Brückl, Matthias W Beckmann, Martin F Fromm, Frank Dörje
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. JCO oncology practice (2024)
Arne Gessner, Fabian Müller, Pia Wenisch, Markus R Heinrich, Jörg König, Peter Stopfer, Martin F Fromm
A metabolomic analysis of sensitivity and specificity of 23 previously proposed biomarkers for renal transporter-mediated drug-drug interactions. Clinical pharmacology and therapeutics (2023)
Niklas Kehl, Arne Gessner, Renke Maas, Martin F Fromm, Regina Verena Taudte
A supervised machine-learning approach for the efficient development of a multi method (LC-MS) for a large number of drugs and subsets thereof: focus on oral antitumor agents. Clinical chemistry and laboratory medicine (2023)
Bastian Haberkorn, Dennis Löwen, Lukas Meier, Martin F Fromm, Martin F Fromm
Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines. Pharmaceutics 15 (3) (2023)
Tom Zimmermann, Sebastian Staebler, Regina Verena Taudte, Sumeyya Ünüvar, Sabine Grösch, Stephanie Arndt, Sigrid Karrer, Martin F Fromm, Anja Katrin Bosserhoff
Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells. Cancers 15 (4) (2023)
Fabian Müller, Kathrin Hohl, Sascha Keller, Sven Schmidt-Gerets, Birgit Deutsch, Annette Schuler-Metz, Martin F Fromm, Peter Stopfer, Arne Gessner
N 1 -Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug-Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid. Clinical pharmacology and therapeutics (2023)
Bastian Haberkorn, Dennis Löwen, Lukas Meier, Martin F Fromm, Martin F Fromm
Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines. Pharmaceutics 15 (3) (2023)
Fabian Graßl, Leonard Bock, Álvaro Huete-Huerta González, Martin Schiller, Peter Gmeiner, Martin F Fromm, Martin F Fromm, Harald Hübner, Markus R Heinrich
Exploring Structural Determinants of Bias among D4 Subtype-Selective Dopamine Receptor Agonists. Journal of medicinal chemistry (2023)
Bastian Haberkorn, Dennis Löwen, Lukas Meier, Martin F Fromm, Martin F Fromm
Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines. Pharmaceutics 15 (3) (2023)
Tom Zimmermann, Sebastian Staebler, Regina Verena Taudte, Sumeyya Ünüvar, Sabine Grösch, Stephanie Arndt, Sigrid Karrer, Martin F Fromm, Anja Katrin Bosserhoff
Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells. Cancers 15 (4) (2023)
Tom Zimmermann, Sebastian Staebler, Regina Verena Taudte, Sumeyya Ünüvar, Sabine Grösch, Stephanie Arndt, Sigrid Karrer, Martin F Fromm, Anja Katrin Bosserhoff
Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells. Cancers 15 (4) (2023)
Daniela B Surrer, Martin F Fromm, Renke Maas, Martin F Fromm
L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact. Metabolites 12 (4) (2022)
Katja Schlichtig, Lisa Cuba, Pauline Dürr, Laura Bellut, Norbert Meidenbauer, Frank Kunath, Peter J Goebell, Andreas Mackensen, Frank Dörje, Martin F Fromm, Bernd Wullich
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial. Journal of clinical medicine 11 (15) (2022)
Melanie I Then, Wahram Andrikyan, Martin F Fromm, Renke Maas
Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative Analysis. Journal of clinical medicine 11 (14) (2022)
Denise Türk, Fabian Müller, Martin F Fromm, Dominik Selzer, Robert Dallmann, Thorsten Lehr
Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N 1 -Methylnicotinamide: A PBPK Modeling Approach. Clinical pharmacology and therapeutics 112 (3) (2022)
Laura Weisbach, Anna K Schuster, Michael Hartmann, Martin F Fromm, Renke Maas, Katrin Farker
Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications-A Systematic Analysis of SmPCs/PI of Major Drug Markets. Journal of clinical medicine 11 (7) (2022)
Pauline Dürr, Florian Meier, Katja Schlichtig, Anja Schramm, Lukas Schötz, Martin F Fromm, Frank Dörje
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial. Journal of clinical medicine 11 (21) (2022)
Muhammad Erfan Uddin, Eric D Eisenmann, Yang Li, Kevin M Huang, Dominique A Garrison, Zahra Talebi, Alice A Gibson, Yan Jin, Mahesh R Nepal, Ingrid M Bonilla, Qiang Fu, Xinxin Sun, Alec Millar, Mikhail Tarasov, Christopher E Jay, Xiaoming Cui, Heidi J Einolf, Ryan M Pelis, Sakima A Smith, Przemysław B Radwański, Douglas H Sweet, Martin F Fromm, Martin F Fromm, Cynthia A Carnes, Shuiying Hu, Alex Sparreboom
MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia. International journal of molecular sciences 23 (15) (2022)
Wahram Andrikyan, Melanie I Then, Karl-Günter Gaßmann, Thomas Tümena, Pauline Dürr, Martin F Fromm, Renke Maas
Use of medication data alone to identify diagnoses and related contraindications: Application of algorithms to close a common documentation gap. British journal of clinical pharmacology 88 (12) (2022)
Shingen Misaka, Yuko Ono, Regina Verena Taudte, Eva Hoier, Hiroshi Ogata, Tomoyuki Ono, Martin F Fromm, Hiroshi Watanabe, Martin F Fromm, Kenju Shimomura
Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers. Clinical pharmacology and therapeutics 112 (3) (2022)
Anne T Nies, Martin F Fromm, Ute Hofmann, Charlotte Kölz, Martin F Fromm, Matthias Schwab
Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters. Pharmaceutics 13 (3) (2021)
Niklas Kehl, Katja Schlichtig, Pauline Dürr, Laura Bellut, Frank Dörje, Rainer Fietkau, Marianne Pavel, Andreas Mackensen, Bernd Wullich, Renke Maas, Martin F Fromm, Arne Gessner, Regina Verena Taudte
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma. Cancers 13 (24) (2021)
Melanie I Then, Wahram Andrikyan, Renke Maas, Martin F Fromm
The CredibleMeds® list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing information. British journal of clinical pharmacology (2021)
Pauline Dürr, Katja Schlichtig, Carolin Kelz, Birgit Deutsch, Renke Maas, Michael J Eckart, Jochen Wilke, Harald Wagner, Kerstin Wolff, Caroline Preuß, Valeska Brückl, Norbert Meidenbauer, Christian Staerk, Andreas Mayr, Rainer Fietkau, Peter J Goebell, Frank Kunath, Matthias W Beckmann, Andreas Mackensen, Markus F Neurath, Marianne Pavel, Frank Dörje, Martin F Fromm
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Oliver J Fischer, Josefa Hofmann, Hannelore Rampp, Jonas Kaindl, Gerald Pratsch, Amelie Bartuschat, R Verena Taudte, Martin F Fromm, Harald Hübner, Peter Gmeiner, Markus R Heinrich
Regiospecific Introduction of Halogens on the 2-Aminobiphenyl Subunit Leading to Highly Potent and Selective M3 Muscarinic Acetylcholine Receptor Antagonists and Weak Inverse Agonists. Journal of medicinal chemistry 63 (8) (2020)
Emir Taghikhani, Renke Maas, Regina Verena Taudte, Arne Gessner, Martin F Fromm, Martin F Fromm
Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and L-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells. Amino acids 52 (6-7) (2020)
Birgit Deutsch, Claudia Neumeister, Ulrich Schwantes, Martin F Fromm, Martin F Fromm
Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium. Molecular pharmaceutics 16 (2) (2019)
Stefan Selch, Anja Chafai, Heinrich Sticht, Andreas L Birkenfeld, Martin F Fromm, Jörg König
Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism. Scientific reports 8 (1) (2018)

Martin F Fromm.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Martin F Fromm